ResearcherYonsei UniversityActive in the last 2 years

Choong‐kun Lee

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5151-5096; OpenAlex author ID A5010037501. Sources: OpenAlex.

Their work

Papers: 8 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 33

Papers, trials and grants by year

2021: 2 papers · 2022: 2 papers · 2023: none · 2024: 3 papers · 2025: 1 paper

Papers 8

Pegylated granulocyte colony-stimulating factor primary prophylaxis versus no prophylaxis in patients with unresectable pancreatic cancer treated with modified… Co-author DOI 10.1016/j.eclinm.2025.103646 ↗
Liposomal irinotecan, oxaliplatin, and S-1 as first-line therapy for patients with locally advanced or metastatic pancreatic adenocarcinoma (NASOX): A multicen… Co-author DOI 10.1016/j.ejca.2024.114194 ↗
Inhibition of the Alternative Complement Pathway May Cause Secretion of Factor B, Enabling an Early Detection of Pancreatic Cancer. Co-author DOI 10.1021/acs.jproteome.3c00695 ↗
Deep-Transfer-Learning-Based Natural Language Processing of Serial Free-Text Computed Tomography Reports for Predicting Survival of Patients With Pancreatic Ca… Last author DOI 10.1200/cci.24.00021 ↗
Combined tumor epithelial and stromal histopathology with keratin 81 expression predicts prognosis for pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/jhbp.1025 ↗
Neoadjuvant FOLFIRINOX Followed by Pancreatoduodenectomy for Pancreatic Cancer in Patients with Previous Transhiatal Esophagectomy for Esophageal Cancer. Co-author DOI 10.1159/000525294 ↗
Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: a multicent… Co-author DOI 10.1016/j.esmoop.2021.100049 ↗
Early Diagnostic Ability of Human Complement Factor B in Pancreatic Cancer Is Partly Linked to Its Potential Tumor-Promoting Role. Co-author DOI 10.1021/acs.jproteome.1c00805 ↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hye Jin Choi · 6 shared papers, 2021–2025 · strength 1.04
- Paper Pegylated granulocyte colony-stimulating factor primary prophylaxis versus no prophylaxis in patients with unresectable… DOI 10.1016/j.eclinm.2025.103646 ↗
- Paper Inhibition of the Alternative Complement Pathway May Cause Secretion of Factor B, Enabling an Early Detection of Pancre… DOI 10.1021/acs.jproteome.3c00695 ↗
- Paper Deep-Transfer-Learning-Based Natural Language Processing of Serial Free-Text Computed Tomography Reports for Predicting… DOI 10.1200/cci.24.00021 ↗
Sung Hyun Kim · 4 shared papers, 2021–2024 · strength 0.68
- Paper Inhibition of the Alternative Complement Pathway May Cause Secretion of Factor B, Enabling an Early Detection of Pancre… DOI 10.1021/acs.jproteome.3c00695 ↗
- Paper Deep-Transfer-Learning-Based Natural Language Processing of Serial Free-Text Computed Tomography Reports for Predicting… DOI 10.1200/cci.24.00021 ↗
- Paper Neoadjuvant FOLFIRINOX Followed by Pancreatoduodenectomy for Pancreatic Cancer in Patients with Previous Transhiatal Es… DOI 10.1159/000525294 ↗
Chang Moo Kang · 4 shared papers, 2021–2024 · strength 0.65
- Paper Inhibition of the Alternative Complement Pathway May Cause Secretion of Factor B, Enabling an Early Detection of Pancre… DOI 10.1021/acs.jproteome.3c00695 ↗
- Paper Combined tumor epithelial and stromal histopathology with keratin 81 expression predicts prognosis for pancreatic ducta… DOI 10.1002/jhbp.1025 ↗
- Paper Neoadjuvant FOLFIRINOX Followed by Pancreatoduodenectomy for Pancreatic Cancer in Patients with Previous Transhiatal Es… DOI 10.1159/000525294 ↗
Ho Kyoung Hwang · 3 shared papers, 2022–2024 · strength 0.52
- Paper Deep-Transfer-Learning-Based Natural Language Processing of Serial Free-Text Computed Tomography Reports for Predicting… DOI 10.1200/cci.24.00021 ↗
- Paper Combined tumor epithelial and stromal histopathology with keratin 81 expression predicts prognosis for pancreatic ducta… DOI 10.1002/jhbp.1025 ↗
- Paper Neoadjuvant FOLFIRINOX Followed by Pancreatoduodenectomy for Pancreatic Cancer in Patients with Previous Transhiatal Es… DOI 10.1159/000525294 ↗
Min Jung Lee · 2 shared papers, 2021–2024 · strength 0.32
- Paper Inhibition of the Alternative Complement Pathway May Cause Secretion of Factor B, Enabling an Early Detection of Pancre… DOI 10.1021/acs.jproteome.3c00695 ↗
- Paper Early Diagnostic Ability of Human Complement Factor B in Pancreatic Cancer Is Partly Linked to Its Potential Tumor-Prom… DOI 10.1021/acs.jproteome.1c00805 ↗
Young‐Ki Paik · 2 shared papers, 2021–2024 · strength 0.32
- Paper Inhibition of the Alternative Complement Pathway May Cause Secretion of Factor B, Enabling an Early Detection of Pancre… DOI 10.1021/acs.jproteome.3c00695 ↗
- Paper Early Diagnostic Ability of Human Complement Factor B in Pancreatic Cancer Is Partly Linked to Its Potential Tumor-Prom… DOI 10.1021/acs.jproteome.1c00805 ↗
Changhoon Yoo · 2 shared papers, 2021–2024 · strength 0.28
- Paper Liposomal irinotecan, oxaliplatin, and S-1 as first-line therapy for patients with locally advanced or metastatic pancr… DOI 10.1016/j.ejca.2024.114194 ↗
- Paper Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with m… DOI 10.1016/j.esmoop.2021.100049 ↗
Jung Ho Kim · 1 shared paper, 2025 · strength 0.25
- Paper Pegylated granulocyte colony-stimulating factor primary prophylaxis versus no prophylaxis in patients with unresectable… DOI 10.1016/j.eclinm.2025.103646 ↗
Mi‐Suk Park · 1 shared paper, 2024 · strength 0.20
- Paper Deep-Transfer-Learning-Based Natural Language Processing of Serial Free-Text Computed Tomography Reports for Predicting… DOI 10.1200/cci.24.00021 ↗
Seung‐seob Kim · 1 shared paper, 2024 · strength 0.20
- Paper Deep-Transfer-Learning-Based Natural Language Processing of Serial Free-Text Computed Tomography Reports for Predicting… DOI 10.1200/cci.24.00021 ↗
Sunkyu Kim · 1 shared paper, 2024 · strength 0.20
- Paper Deep-Transfer-Learning-Based Natural Language Processing of Serial Free-Text Computed Tomography Reports for Predicting… DOI 10.1200/cci.24.00021 ↗
Michael Cecchini · 1 shared paper, 2024 · strength 0.20
- Paper Deep-Transfer-Learning-Based Natural Language Processing of Serial Free-Text Computed Tomography Reports for Predicting… DOI 10.1200/cci.24.00021 ↗
Zev A. Wainberg · 1 shared paper, 2024 · strength 0.18
- Paper Liposomal irinotecan, oxaliplatin, and S-1 as first-line therapy for patients with locally advanced or metastatic pancr… DOI 10.1016/j.ejca.2024.114194 ↗
Hyehyun Jeong · 1 shared paper, 2024 · strength 0.18
- Paper Liposomal irinotecan, oxaliplatin, and S-1 as first-line therapy for patients with locally advanced or metastatic pancr… DOI 10.1016/j.ejca.2024.114194 ↗
Kyu‐pyo Kim · 1 shared paper, 2024 · strength 0.18
- Paper Liposomal irinotecan, oxaliplatin, and S-1 as first-line therapy for patients with locally advanced or metastatic pancr… DOI 10.1016/j.ejca.2024.114194 ↗
Do Hyun Park · 1 shared paper, 2024 · strength 0.18
- Paper Liposomal irinotecan, oxaliplatin, and S-1 as first-line therapy for patients with locally advanced or metastatic pancr… DOI 10.1016/j.ejca.2024.114194 ↗
Dae Young Zang · 1 shared paper, 2024 · strength 0.18
- Paper Liposomal irinotecan, oxaliplatin, and S-1 as first-line therapy for patients with locally advanced or metastatic pancr… DOI 10.1016/j.ejca.2024.114194 ↗
Tae Jun Song · 1 shared paper, 2024 · strength 0.18
- Paper Liposomal irinotecan, oxaliplatin, and S-1 as first-line therapy for patients with locally advanced or metastatic pancr… DOI 10.1016/j.ejca.2024.114194 ↗
Sung‐Hoon Moon · 1 shared paper, 2024 · strength 0.18
- Paper Liposomal irinotecan, oxaliplatin, and S-1 as first-line therapy for patients with locally advanced or metastatic pancr… DOI 10.1016/j.ejca.2024.114194 ↗
Inkeun Park · 1 shared paper, 2024 · strength 0.18
- Paper Liposomal irinotecan, oxaliplatin, and S-1 as first-line therapy for patients with locally advanced or metastatic pancr… DOI 10.1016/j.ejca.2024.114194 ↗
Baek‐Yeol Ryoo · 1 shared paper, 2024 · strength 0.18
- Paper Liposomal irinotecan, oxaliplatin, and S-1 as first-line therapy for patients with locally advanced or metastatic pancr… DOI 10.1016/j.ejca.2024.114194 ↗
Dongwook Oh · 1 shared paper, 2024 · strength 0.18
- Paper Liposomal irinotecan, oxaliplatin, and S-1 as first-line therapy for patients with locally advanced or metastatic pancr… DOI 10.1016/j.ejca.2024.114194 ↗
Seung Soo Hong · 1 shared paper, 2022 · strength 0.16
- Paper Neoadjuvant FOLFIRINOX Followed by Pancreatoduodenectomy for Pancreatic Cancer in Patients with Previous Transhiatal Es… DOI 10.1159/000525294 ↗
Eunhyang Park · 1 shared paper, 2022 · strength 0.16
- Paper Combined tumor epithelial and stromal histopathology with keratin 81 expression predicts prognosis for pancreatic ducta… DOI 10.1002/jhbp.1025 ↗
Juwan Kim · 1 shared paper, 2022 · strength 0.16
- Paper Neoadjuvant FOLFIRINOX Followed by Pancreatoduodenectomy for Pancreatic Cancer in Patients with Previous Transhiatal Es… DOI 10.1159/000525294 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.